Malignant Hepatobiliary Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-08-06
Clinical Trial Update: Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions [Phase 2]
Phase 2 trial evaluating ponatinib hydrochloride in patients with advanced biliary cancer harboring FGFR2 fusions; study completed with post…